M EVR7 Pill - white capsule-shape
Pill with imprint M EVR7 is White, Capsule-shape and has been identified as Everolimus 7.5 mg. It is supplied by Mylan Pharmaceuticals Inc.
Everolimus is used in the treatment of neuroendocrine carcinoma; breast cancer; organ transplant, rejection prophylaxis; pancreatic cancer; renal angiomyolipoma and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M EVR7
Everolimus
- Imprint
- M EVR7
- Strength
- 7.5 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- MTOR inhibitors, Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-3098
Related images for "M EVR7"
More about everolimus
- Check interactions
- Pricing & coupons
- Reviews (29)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: mTOR inhibitors
- Breastfeeding
- En español
Patient resources
- Drug Information
- Everolimus Tablets (Afinitor)
- Everolimus Tablets (Zortress)
- Everolimus Tablets For Oral Suspension
Other brands
Afinitor, Zortress, Afinitor Disperz
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
